Jiangsu Hengrui Pharmaceuticals and its partner Elevar Therapeutics will have to wait even longer before their PD-1 inhibitor ...

A  team of researchers from Cleveland Clinic share insights from an early set of 19,000 patients to receive immune checkpoint inhibitor treatments for colorectal cancer in the US.   The report comes ...

Patients in the pembrolizumab-olaparib arm had clinically meaningful improvements in PFS over patients in the control arm.

Promising therapies for platinum-resistant ovarian cancer produced mixed results in separate trials. The AKT inhibitor ...

Metastatic breast cancer is complex, requiring holistic care and ongoing treatment, with varying prognosis depending on ...

Version of Record: This is the final version of the article. This study investigated the role of PLECTIN, a cytoskeletal crosslinker protein, in liver cancer formation and progression. Using the liver ...

Clinically, cancer is characterized by the uncontrollable division of cells, which can multiply and spread, making the condition life-threatening. Treatment strategies have evolved significantly, with ...

This drug blocks a protein called mTOR, which helps cancer cells grow ... stops the checkpoint protein PD-1 from attaching to another protein, PD-L1, that sits on the surface of T cells.

Inmate shot inside Kingwood hospital by San Jacinto County deputy, investigation underway (Copyright 2025 by KPRC Click2Houston - All rights reserved.) It all started ...

mTOR inhibitors. Everolimus (Afinitor) is a drug that blocks the mTOR protein and helps stop the growth and spread of cancer cells. PI3K inhibitors. Alpelisib (Piqray) and inavolisib (Itovebi ...